Correlation between the functional assay for activated protein c resistance and factor V Leiden in the neonate

Pediatric Research

Volumn 42, Issue 6, 1997, Pages 776-778

  Sifontes, Maria T ^a,b   Nuss, Rachelle ^a   Hunger, Stephen P ^a   Jacobson, Linda J ^a   Waters, Jill ^a   Manco Johnson, Marilyn J ^a  

^a Children's Hospital Colorado   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; ARGININE; BLOOD CLOTTING FACTOR 5; LYSINE;

ARTICLE; BLOOD SAMPLING; DNA DETERMINATION; GENE MUTATION; GROWTH REGULATION; HUMAN; HUMAN CELL; HYPERCOAGULABILITY; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; THROMBOSIS; UMBILICAL CORD BLOOD;

EID: 0030723663     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/00006450-199712000-00009     Document Type: Article

References (24)

1. Koster T, Rosendaal FR, DeRonde H, Briet E, Vandenbrouke JP, Bertina RM 1993 Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden thrombophilia study. Lancet 342:1503-1506
2. Griffin JH, Evatt B, Wideman C, Fernandez JA 1993 Anticoagulant protein C pathway defective in majority of thrombophilic patients. Blood 82:1989-1993
3. Bertina RM, Koeleman BPC, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, van der Velden PA, Reitsma PH 1994 Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369:64-67
4. Greengard JS, Sun X, Xu X, Femandez JA, Griffin JH, Evatt B 1994 Activated protein C resistance caused by Arg506GIn mutation in factor Va. Lancet 343:1361-1362
5. Voorberg J, Roelse J, Koopman R, Buller H, Berends F, ten Cate JW, Mertens K, van Mourik SA 1994 Association of idiopathic venous thromboembolism with single point mutation at Arg 506 of factor V. Lancet 343:1535-1536
6. Svensson PJ, Dahlbäck B 1994 Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med 330:517-522
7. Rees DC, Cox M, Cless JB 1995 World distribution of factor V Leiden. Lancet 346:1133-1134
8. Dahlbäck B 1995 Inherited tnrombophilia: resistance to activated protein C as a pathogenic factor of venous thrombosis. Blood 85:607-614
9. Ridker PM, Hennekens CH, Lindpaintner K, Stampfer MJ, Eisenberg PR, Miletich JP 1995 Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. N Engl J Med 332:912-917
10. Manco-Johnson MJ 1994 Disseminated intravascular coagulation and other hypercoagulable syndromes. Int J Pediatr Hematol Oncol 1:1-23
11. Manco-Johnson MJ 1990 Diagnosis and management of thromboses in the perinatal period. Semin Perinatol 14:393-402
12. Manco-Johnson MJ, Nuss R, Jacobson LJ, Hathaway \VW 1994 Activated protein C cofactor is increased in neonates. Blood 84:A330
13. Le DT, Griffin JH, Greengard JS, Mujumdar V, Rapaport SI 1995 Use of a generally applicable tissue factor dependent factor V assay to detect activated protein C resistant factor Va in patients receiving warfarin and in patients with a lupus anticoagulant. Blood 85:1704-1711
14. Sifontes MT, Nuss R, Hunger SP, Wilimas J, Jacobson U, Manco-Johnson MJ 1997 The factor V Leiden mutation in children with cancer and thrombosis. Br J Haematol 96:484-489
15. Svensson PJ, Zoller B, Dahlbäck B 1997 Evaluation of original and modified APC-resistance tests in unselected outpatients with clinically suspected thrombosis and in healthy controls. Thromb Haemostasis 77:332-335
16. Ridker PM, Miletich JP, Hennekens CH, Buring JE 1997 Ethnic distribution of factor V Leiden in 4047 men and women. Implications for venous thromboembolism screening. JAMA 277:1305-1307
17. De Stefano V 1987 Antithrombin in full-term and pre-term newborn infants: three cases of neonatal diagnosis of ATcongenital defect. Thromb Haemostasis 57:329331
18. Brenner B 1988 Cerebral thrombosis in a newborn with a congenital deficiency of antithrombin III. Am J Hematol 27:209-211
19. Jochmans K 1994 Antithrombin-GIy 424 Arg: a novel point mutation responsible for type 1 antithrombin deficiency and neonatal thrombosis. Blood 83:146-151
20. Rogers PC, Suva MP, Carter JE, Wadsworth LD 1989 Renal vein thrombosis and response to therapy in a newborn due to protein C deficiency. Eur J Pediatr 149:124-125
21. Goodwin TM, Gazit G, Gordon EM 1995 Heterozygous protein C deficiency presenting as severe protein C deficiency and peripartum thrombosis: successful treatment with protein C concentrate. Obstet Gynecol 86:662-664
22. Formstone CJ, Hallam PJ, Tuddenham EG, Voke J, Layton M, Nicolaides K, Kann IM, Cooper DN 1996 Severe perinatal thrombosis in double and triple heterozygous offspring of a family segregating two independent protein S mutations and a protein C mutation. Blood 87:3731-3737
23. Pipe SW, Schmaier AH, Nichols WC, Ginsburg D, Bozynski MEA, Castle VP 1996 Neonatal purpura fulminans in association with factor V R506Q mutation. J Pediatr 128:706-709
24. Hathaway WE, Bonnar J 1987 Hemostatic Disorders of the Pregnant Woman and Newborn Infant. Elsevier Publishing, New York, p 58